
Cingulate shares plans to resubmit its ADHD candidate CTx-1301 to the FDA, following a CRL tied to CMC information requests
The clinical presentation and functional impacts of ADHD in adults vary greatly from their child and adolescent counterparts.
View a PDF of this article.